Table 2. Comparison of allele frequencies of EGFR mutations in cfDNA samples of NSCLC patients as determined by digital PCR and targeted sequencing.
Case No | EGFR mutation | Allele frequency in pre-RT by digital PCR (copy/mL) | Allele frequency during RT by digital PCR (copy/mL) | Allele frequency in pre-RT by targeted sequencing | Allele frequency during RT by targeted sequencing |
---|---|---|---|---|---|
case 1 | - | - | - | N.D. | 7.8% (G719C) |
case 2 | L858R | N.D (0) | 0.9% (10562) | N.D. | 0.5% |
case 12 | exon 19 del. | 0.2% (20866) | 0.4% (139579) | N.D. | N.D. |
case 15 | L858R | 44194 (0·5%) | 2.3%(363269) | 0.3% | 1.5% |
T790M | N.D. (0) | 0.4% (40824) | N.D. | 0.3% | |
case 16 | L858R | (N.D.) | 0·2% | N.D. | 2.8% |
L747S | - | - | N.D. | 2.3% | |
case 17 | exon 19 del. | N.D. (64282) | 6.4% (2122718) | 0.3% | 7.3% |
Note: del., deletion; N.D., not determined; RT, radiotherapy.